Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

April 23, 2024

Study Completion Date

April 23, 2024

Conditions
Healthy Adult Participants
Interventions
DRUG

ACC017 tablets

ACC017 tablets 5 mg, 20 mg, 40 mg, 80 mg, 120 mg, and 160 mg (tentative) with matching placebo

DRUG

Emtricitabine and Tenofovir Alafenamide Fumarate Tablets

Participants received a single oral dose of ACC017 tablets with emtricitabine and tenofovir alafenamide fumarate tablets under the fasting condition.

Trial Locations (1)

100015

RECRUITING

Beijing Ditan Hospital Capital Medical University, Beijing

All Listed Sponsors
collaborator

Chengdu Aidea Pharmaceutical Technology Co., Ltd

INDUSTRY

lead

Jiangsu Aidea Pharmaceutical Co., Ltd

INDUSTRY

NCT06278389 - Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants | Biotech Hunter | Biotech Hunter